Page 15 - AIH-1-2
P. 15

Artificial Intelligence in Health                                         AI in the battle against COVID-19



            10.1. Country-specific implementations               These case studies underscore the importance of careful

            10.1.1. South Korea’s AI-powered response          management of AI applications in pandemic response
                                                               efforts. Success depends not only on the technology itself
            South  Korea’s response to the COVID-19 pandemic is   but also on factors such as data quality, user engagement,
            a prime example of effective AI implementation. The   and the ethical use of AI.
            country’s swift action in developing AI-driven testing,
            tracing, and treatment strategies resulted in the efficient   11. Future directions
            containment of the virus. AI algorithms were employed to   The COVID-19 pandemic has accelerated the integration of
            analyze travel and medical data, facilitating rapid contact   AI in healthcare and public health. Looking ahead, several
            tracing and targeted testing. 86-88  Chatbot services such as   emerging technologies and policy recommendations could
            the Korean COVID-19 chatbot provided citizens with real-  shape the next phase of AI in pandemic preparedness and
            time information by integrating public data from the Korea   response.
            Centers for Disease Control and Prevention and Ministry
            of Health and Welfare,  thereby easing the burden on   11.1. Emerging technologies
                               89
            national health-care hotlines.                     Quantum computing holds the promise of processing
            10.1.2. Singapore’s TraceTogether program          complex datasets much faster than traditional computers.
                                                               In the context of pandemics, quantum algorithms could
            Singapore launched the TraceTogether program, which   revolutionize the way we model viral spread, optimize
            utilized a mobile application and token-based system to   supply chains for medical supplies, and discover new
            facilitate digital contact tracing.  The technology behind   therapeutic drugs. 96
                                      90
            the program assessed the proximity and duration of user
            interactions to notify individuals of potential exposure   Next-generation sequencing  (NGS) technologies are
            to the virus. While innovative, the program encountered   rapidly evolving, allowing for quicker and more affordable
            challenges related to user privacy and data security. 91  genomic sequencing. AI, combined with NGS, could
                                                               enable real-time tracking of pathogen evolution, helping
            10.1.3. The United States’ vaccine distribution    public health officials stay ahead of mutations and variants
                                                               of concern. 97
            In the United States, AI played a crucial role in optimizing
            vaccine distribution logistics. Recurrent neural networks   Blockchain technology offers a secure and transparent
            helped identify optimal locations for vaccine centers and   way to manage health data. In pandemics, blockchain can
            manage supply chains. However, the reliance on AI also led   ensure the integrity of health records, facilitate secure data
            to some disparities in vaccine allocation, highlighting the   sharing  for  AI  algorithms,  and  support  contact  tracing
            need for oversight in AI implementations. 92       efforts without compromising privacy. 98
            10.2. Success stories and failures                 11.2. Policy recommendations
            AI-driven diagnostic tools have emerged as a success story,   Robust data governance frameworks are essential to ensure
            with algorithms such as those developed by DeepMind   that AI systems have access to high-quality, representative
            capable of predicting the structure of proteins associated   data while safeguarding individual privacy. Policies must
            with SARS-CoV-2, the virus causing COVID-19.  This   be  developed  to  address  data  ownership,  consent,  and
                                                     93
            breakthrough holds implications for understanding the   anonymization. 99
            virus’s mechanisms and developing treatments.        Given the global nature of pandemics, international
              Moreover, AI has proven successful in disseminating   cooperation is imperative. Policy recommendations should
            public health messaging via social media platforms,   encourage the sharing of AI technologies and expertise
            chatbots, and other digital means. These AI systems have   across borders, as well as fostering collaborative efforts in
            effectively  tailored  messages  to  specific  demographics,   research and development. 100
            thereby  improving  public  engagement  and  compliance   To fully harness the potential of AI, investments in
            with health guidelines. 94                         education and workforce development are crucial. This
              Conversely, some AI predictive models have failed to   effort includes training healthcare professionals in AI
            provide accurate forecasts for the spread of the virus. In   applications and promoting AI literacy among the general
                                                                        101
            many instances, these models were unable to account for   population.
            the dynamic nature of human behavior and policy changes,   The future of AI in the context of pandemics is
            leading to over- or under-estimation of case numbers. 95  promising, with emerging technologies offering new tools


            Volume 1 Issue 2 (2024)                         9                                doi: 10.36922/aih.2401
   10   11   12   13   14   15   16   17   18   19   20